Ask AI
ProCE Banner Activity

Heart Failure and MRAs: Diving Deep Into the Pivotal FINEARTS-HF Trial 

Podcast Episodes

Listen in as Ty J. Gluckman, MD, MHA, discusses the pivotal phase III FINEARTS-HF trial and how the treatment landscape is evolving for patients with heart failure with mildly reduced or preserved ejection fraction, including the emerging role of mineralocorticoid receptor antagonists.

Released: June 19, 2025

Expiration: June 18, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an independent medical education grant from Bayer HealthCare Pharmaceuticals, Inc.

Bayer HealthCare Pharmaceuticals Inc.

Disclosure

Primary Author

Ty J. Gluckman, MD, MHA, has no relevant financial relationships to disclose.